Ibrutinib-associated atrial fibrillation treatment with catheter ablation

Guardado en:

Detalles Bibliográficos
Autores principales:	Ridhima Kapoor, MD, Muhammad Fazal, MD, Paul Cheng, MD, Ronald Witteles, MD, June-Wha Rhee, MD, Tina Baykaner, MD, MPH
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Atrial fibrillation Catheter ablation Ibrutinib Lymphoma Tyrosine kinase inhibitors Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/517cdb11f2d24d0785702b9eaeb92f6f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:517cdb11f2d24d0785702b9eaeb92f6f
record_format	dspace
spelling	oai:doaj.org-article:517cdb11f2d24d0785702b9eaeb92f6f2021-11-16T04:10:35ZIbrutinib-associated atrial fibrillation treatment with catheter ablation2214-027110.1016/j.hrcr.2021.08.003https://doaj.org/article/517cdb11f2d24d0785702b9eaeb92f6f2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214027121001603https://doaj.org/toc/2214-0271Ridhima Kapoor, MDMuhammad Fazal, MDPaul Cheng, MDRonald Witteles, MDJune-Wha Rhee, MDTina Baykaner, MD, MPHElsevierarticleAtrial fibrillationCatheter ablationIbrutinibLymphomaTyrosine kinase inhibitorsDiseases of the circulatory (Cardiovascular) systemRC666-701ENHeartRhythm Case Reports, Vol 7, Iss 11, Pp 713-716 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Atrial fibrillation Catheter ablation Ibrutinib Lymphoma Tyrosine kinase inhibitors Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Atrial fibrillation Catheter ablation Ibrutinib Lymphoma Tyrosine kinase inhibitors Diseases of the circulatory (Cardiovascular) system RC666-701 Ridhima Kapoor, MD Muhammad Fazal, MD Paul Cheng, MD Ronald Witteles, MD June-Wha Rhee, MD Tina Baykaner, MD, MPH Ibrutinib-associated atrial fibrillation treatment with catheter ablation
format	article
author	Ridhima Kapoor, MD Muhammad Fazal, MD Paul Cheng, MD Ronald Witteles, MD June-Wha Rhee, MD Tina Baykaner, MD, MPH
author_facet	Ridhima Kapoor, MD Muhammad Fazal, MD Paul Cheng, MD Ronald Witteles, MD June-Wha Rhee, MD Tina Baykaner, MD, MPH
author_sort	Ridhima Kapoor, MD
title	Ibrutinib-associated atrial fibrillation treatment with catheter ablation
title_short	Ibrutinib-associated atrial fibrillation treatment with catheter ablation
title_full	Ibrutinib-associated atrial fibrillation treatment with catheter ablation
title_fullStr	Ibrutinib-associated atrial fibrillation treatment with catheter ablation
title_full_unstemmed	Ibrutinib-associated atrial fibrillation treatment with catheter ablation
title_sort	ibrutinib-associated atrial fibrillation treatment with catheter ablation
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/517cdb11f2d24d0785702b9eaeb92f6f
work_keys_str_mv	AT ridhimakapoormd ibrutinibassociatedatrialfibrillationtreatmentwithcatheterablation AT muhammadfazalmd ibrutinibassociatedatrialfibrillationtreatmentwithcatheterablation AT paulchengmd ibrutinibassociatedatrialfibrillationtreatmentwithcatheterablation AT ronaldwittelesmd ibrutinibassociatedatrialfibrillationtreatmentwithcatheterablation AT junewharheemd ibrutinibassociatedatrialfibrillationtreatmentwithcatheterablation AT tinabaykanermdmph ibrutinibassociatedatrialfibrillationtreatmentwithcatheterablation
_version_	1718426722554085376

Ibrutinib-associated atrial fibrillation treatment with catheter ablation

Ejemplares similares